Bennicas & Associates, Inc. / ABBV
Bennicas & Associates, Inc.’s Abbvie Inc Position
Does Bennicas & Associates, Inc. own Abbvie Inc (ABBV)? Yes — 35.4K shares worth $6M (+3.31% of its 13F portfolio) as of Q1 2023.
Position Value
$6M
Q1 2023
Shares
35.4K
% of Portfolio
+3.31%
Quarters Held
18
currently held
Position History ABBV
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2023 | 35.4K | $6M | +3.31% |
| Q4 2022 | 35.4K | $6M | +3.30% |
| Q3 2022 | 36.3K | $5M | +3.11% |
| Q2 2022 | 36.7K | $6M | +3.28% |
| Q1 2022 | 36.8K | $6M | +2.99% |
| Q4 2021 | 40.9K | $6M | +2.88% |
| Q3 2021 | 41.1K | $4M | +2.49% |
| Q2 2021 | 41.4K | $5M | +2.57% |
| Q1 2021 | 41.4K | $4M | +2.57% |
| Q4 2020 | 43.7K | $5M | +2.73% |
| Q3 2020 | 44.1K | $4M | +2.40% |
| Q2 2020 | 44.3K | $4M | +3.26% |
| Q1 2020 | 44.6K | $3M | +3.00% |
| Q4 2019 | 48.5K | $4M | +3.10% |
| Q3 2019 | 54.6K | $4M | +3.21% |
| Q2 2019 | 14.7K | $1M | +0.89% |
| Q1 2019 | 14.9K | $1M | +1.06% |
| Q4 2018 | 15.0K | $1M | +1.28% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bennicas & Associates, Inc.’s full portfolio or all institutional holders of ABBV.